Cargando…
Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease
Advanced glycation end products (AGEs) are aging products. In chronic kidney disease (CKD), AGEs accumulate due to the increased production, reduced excretion, and the imbalance between oxidant/antioxidant capacities. CKD is therefore a model of aging. The aim of this review is to summarize the pres...
Autores principales: | Dozio, Elena, Caldiroli, Lara, Molinari, Paolo, Castellano, Giuseppe, Delfrate, Nicholas Walter, Romanelli, Massimiliano Marco Corsi, Vettoretti, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045600/ https://www.ncbi.nlm.nih.gov/pubmed/36978832 http://dx.doi.org/10.3390/antiox12030584 |
Ejemplares similares
-
Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2022) -
In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022) -
Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study
por: Molinari, Paolo, et al.
Publicado: (2023) -
Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress
por: Dozio, Elena, et al.
Publicado: (2021) -
Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
por: Dozio, Elena, et al.
Publicado: (2020)